Literature DB >> 9291995

Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials.

M C Gonzalvo1, F Gil, A F Hernández, E Villanueva, A Pla.   

Abstract

Inhibition of paraoxon hydrolase (paraoxonase) activity by 'in vitro' exposure to EDTA, Mg2+, Co2+, Ba2+, La3+, Zn2+, Cu2+, Hg2+, p-hydroxymercuribenzoate (p-OH-MB) and phenyl mercuric acetate (PMA) was investigated in human liver microsomes. Enzyme activity was totally inhibited by 1 mM EDTA in a time-dependent manner, in contrast to previous data obtained in rat liver where an EDTA-resistant fraction was detected. The possible influence of postmortem changes in these results was checked in a parallel experiment using rat livers with different postmortem intervals. From our results the existence in human liver of an EDTA-resistant fraction cannot be discarded. Ba, La and PMA showed immediate inhibition. By contrast the other compounds tested were time-dependent inhibitors. Ba and Zn showed the highest IC50 values. Cu and mercurials (Hg, p-OH-MB, PMA) were the most potent inhibitors of human liver paraoxonase. Kinetic analysis (Lineweaver-Burk and Dixon plots) indicated that different inhibitors exhibit different inhibition patterns: competitive (EDTA, Ba, La, Cu, p-OH-MB and PMA), non competitive (Zn) and mixed (Hg). The pretreatment of sample with dithiothreitol (DTT) protects against the inhibitory effect of mercurials. Furthermore after inhibition by mercurials the activity was restored by DTT. These results confirmed the essential role of the -SH groups to maintain the catalytic activity of paraoxonase and suggest the existence of two types of -SH groups that could differ in their localization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291995     DOI: 10.1016/s0009-2797(97)00046-x

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  20 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.

Authors:  Gurpreet Kaur; A K Jain; Sandeep Singh
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

3.  The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro.

Authors:  V Ancrenaz; J Desmeules; R James; P Fontana; J-L Reny; P Dayer; Y Daali
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.

Authors:  Olivia Drescher; Eric Dewailly; Caroline Diorio; Nathalie Ouellet; Elhadji Anassour Laouan Sidi; Belkacem Abdous; Beatriz Valera; Pierre Ayotte
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-01-22       Impact factor: 5.563

5.  Dietary cholesterol increases paraoxonase 1 enzyme activity.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Karen S Nakayama; Ella R Jarvik; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-08-15       Impact factor: 5.922

6.  Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.

Authors:  Jiang Li; Shao-Feng Xu; Ying Peng; Nan Feng; Ling Wang; Xiao-Liang Wang
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

Review 7.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

8.  Structural Basis of Lysosomal Phospholipase A2 Inhibition by Zn2.

Authors:  Renee A Bouley; Vania Hinkovska-Galcheva; James A Shayman; John J G Tesmer
Journal:  Biochemistry       Date:  2019-03-13       Impact factor: 3.162

9.  Measurement of serum paraoxonase-1 activity in the evaluation of liver function.

Authors:  Jordi Camps; Judit Marsillach; Jorge Joven
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

10.  Contributions of intestine and plasma to the presystemic bioconversion of vicagrel, an acetate of clopidogrel.

Authors:  Zhixia Qiu; Ning Li; Ling Song; Yang Lu; Jing Jing; Harendra S Parekha; Wenchao Gao; Fengjie Tian; Xin Wang; Shuangxia Ren; Xijing Chen
Journal:  Pharm Res       Date:  2013-09-14       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.